Congress:
ECR25
Poster Number:
C-16137
Type:
Poster: EPOS Radiologist (scientific)
Authorblock:
J. Aleem, R. Rai, S. Sattar; Birmingham/UK
Disclosures:
Javaria Aleem:
Nothing to disclose
Rupinder Rai:
Nothing to disclose
Sandeela Sattar:
Nothing to disclose
Keywords:
Artificial Intelligence, Breast, Contrast agents, Mammography, MR, Ultrasound, Biopsy, Radiation effects, Teleradiology, Abscess, Cancer, Cysts
The very high-risk breast cancer screening recall rate in our screening service is higher than the standard NHS screening rate. There is a low recall threshold in very high-risk breast screening MRI reporting due to multiple factors. The high percentage of benign biopsies in our data is reassuring and provides convincing evidence to dismiss biopsies of benign-appearing lesions on the MRI. This will help reduce the recall rate and the emotional burden on the patients.
Recommendations:
- Improve the quality of MRI Breast by reviewing radiographer techniques and reducing artefacts.
- Ensure LMP dates are recorded as accurately as possible.
- Consider introducing enhancement/kinetic curves to characterise the benign lesions precisely in indeterminate and small lesions and optimise recall rates.
- There should be a consensus among 2 or 3 radiologists regarding recalling to assess indeterminate lesions.